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Abstract
Background: Mitotic recombination is important for inactivating tumour suppressor genes by copy-neutral loss of
heterozygosity (LOH). Although meiotic recombination maps are plentiful, little is known about mitotic recombination.
The APC gene (chr5q21) is mutated in most colorectal tumours and its usual mode of LOH is mitotic recombination.
Methods: We mapped mitotic recombination boundaries ("breakpoints") between the centromere (~50 Mb) and APC
(~112 Mb) in early colorectal tumours.
Results: Breakpoints were non-random, with the highest frequency between 65 Mb and 75 Mb, close to a low copy
number repeat region (68–71 Mb). There were, surprisingly, few breakpoints close to APC, contrary to expectations
were there constraints on tumorigenesis caused by uncovering recessive lethal alleles or if mitotic recombination were
mechanistically favoured by a longer residual chromosome arm. The locations of mitotic and meiotic recombination
breakpoints were correlated, suggesting that the two types of recombination are influenced by similar processes,
whether mutational or selective in origin. Breakpoints were also associated with higher local G+C content. The
recombination and gain/deletion breakpoint maps on 5q were not, however, associated, perhaps owing to selective
constraints on APC dosage in early colorectal tumours. Since polymorphisms within the region of frequent mitotic
recombination on 5q might influence the frequency of LOH, we tested the 68–71 Mb low copy number repeat and nearby
tagSNPs, but no associations with colorectal cancer risk were found.
Conclusion: LOH on 5q is non-random, but local factors do not greatly influence the rate of LOH at APC or explain
inter differential susceptibility to colorectal tumours.
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Background
Germline mutations in the APC  gene (chromosome
5q21) result in familial adenomatous polyposis (FAP,
OMIM 175100), a dominantly inherited colorectal
tumour predisposition syndrome. Adenomas start to
grow in the colorectum of patients with FAP when a cell
acquires a somatic "second hit" at the APC locus, leading
to loss of critical APC functions [1]. The position and type
of the "second hit" in FAP are non-random and depend
on the localization of the germline mutation. FAP patients
with germline APC mutations around codon 1300 mainly
acquire "second hits" by loss of heterozygosity in their
colorectal tumours and these patients generally develop
severe disease; by comparison, colorectal tumours in
patients with germline mutations outside this region are
associated with "second hits" in the form of protein-trun-
cating mutations [2]. Somatic APC mutations also occur
in up to 85% of sporadic colorectal tumours and a similar
association between "first hit" and "second hit" is seen. In
general, as a result of these selective constraints on APC in
early tumours, LOH at APC occurs by mitotic recombina-
tion (break-induced replication), causing reduction to
homozygosity but no copy number change [3].
LOH probably occurs most often as a result of repair of a
DNA double-stand break (DSB). Unrepaired DSBs can
cause LOH by deletion. However, the cell has several ways
to repair DSBs, those most commonly used being non-
homologous end-joining or homologous recombination
repair [4]. DSBs are thus an important initiator of recom-
bination events. Using the sister chromatid as a template
for recombination is preferred, as this results in precise
repair with no loss of sequence information (sister chro-
matid exchange, SCE). Such events are generally geneti-
cally undetectable. In contrast, if the non-sister chromatid
of the homologous chromosome acts as a template for
mitotic recombination, half of the daughter cells will have
loss of heterozygosity (LOH) distal to the recombination
breakpoint site after cell division. LOH by mitotic recom-
bination can therefore be seen as a form of DNA repair,
but it is only partially effective. Defects in mitotic recom-
bination underlie rare conditions such as Bloom and
Werner syndromes (OMIM 210900, OMIM 277700,
http://www.ncbi.nlm.nih.gov/sites/OMIM), and these
syndromes are associated with an elevated cancer risk. In
tumours, LOH by mitotic recombination often involves
large chromosomal segments extending from several meg-
abases to whole chromosome arms.
Meiotic recombination has been the subject of numerous
studies, but little is understood about the underlying fac-
tors that lead to mitotic recombination. The studies of
meiotic recombination have shown, for example, that the
locations of crossovers cluster and vary according to local
sequence context and that the probability of recombina-
tion can be associated with common germline sequence
variants [5,6]. In one of the view studies to date, Hagstrom
et al [7] mapped the locations of mitotic recombination
'breakpoints' in retinoblastomas proximal to the RB1
locus on chromosome 13q. Suggestive evidence of break-
point clustering was found, although the map density was
relatively low.
In this study, we set out to improve our understanding of
mitotic recombination by characterising LOH break-
points proximal to the APC locus in colorectal tumours.
We examined the relationship of these breakpoints to
sequence features. Furthermore, we hypothesised that if
the likelihood of mitotic recombination at APC depended
on local sequence variants, there would be clinical impli-
cations, because individuals with an inherited tendency to
LOH at APC might have an increased risk of colorectal
cancer. We sought out to test this hypothesis by relating
sequence variants close to the recombination breakpoints
to colorectal cancer susceptibility.
Methods
Samples
DNA was extracted from 54 CRC cell lines (C10, C32,
C70, C75, C80, C99, C106, C125PM, C170, CACO2,
CL11, COLO201, COLO205, COLO320, COLO678,
COLO741, CX1, GP5D, H508, H716, HCA7, HCA46,
HCT8, HCT116, HCT15/DLD1, HRA19, HT29, HT55,
HT115, HUTU80, LOVO, LIM1863, LS1034, LS123,
LS174T, LS411, MBDA8, NCI-H747, PC/JW, RKO,
SKCO1, SNUC2B, SW1116, SW1222, SW1417, SW403,
SW48, SW620, SW837, SW948, T84, VACO4S, VACO5,
VACO10MS).
Research was undertaken in compliance with the Helsinki
Declaration and with full ethical approval (Oxfordshire
REC B, 05/Q1605/66). 268 anonymised, formalin-fixed,
paraffin-embedded (FFPE) samples of colorectal adeno-
mas from thirteen FAP patients with FAP were identified.
In order to increase the frequency of tumours showing
LOH, we selected cases with germline mutations around
codon 1300. We also used larger lesions (> 0.5 cm diam-
eter) to minimise problems of polyclonality in smaller
colorectal adenomas [8]. For 10 of the larger polyps
(diameter ≤ 0.9 cm), more than one sample was obtained
from different parts of the same polyp in order to check
for consistency of the molecular data, although in each
case, complete concordance was observed. After enrich-
ment for dysplastic epithelium using a fine gauge needle
and the dissecting microscope, DNA was extracted from
each adenoma using a standard proteinase K digestion
and the Qiagen DNeasy kit, except that elution with water
was undertaken twice to increase the yield. Normal tissue
from the same block was extracted using the same
method.BMC Medical Genetics 2009, 10:54 http://www.biomedcentral.com/1471-2350/10/54
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For analysis of associations between mitotic recombina-
tion breakpoints and colorectal cancer risk, two case-con-
trol series were analysed: (i) cases and controls from the
UK CORGI study of familial colorectal tumour patients
[9]; and (ii) cases from the VICTOR http://www.octo-
oxford.org.uk/alltrials/infollowup/vic.html and QUASAR
2 http://www.octo-oxford.org.uk/alltrials/trials/q2.html
clinical trials and controls from the UK 1958 Birth Cohort
http://www.b58cgene.sgul.ac.uk/. All cases and controls,
comprising about 4,000 samples in total, were of white
UK ethnic origin. Further details of ascertainment, inclu-
sion criteria and exclusion criteria can be found in [9].
Genotyping data were derived from the Illumina Hap300,
Hap370 or Hap550 arrays (see below). Each series was
analysed separately for significant allele or genotype fre-
quency differences between cases and controls, followed
by a weighted meta-analysis using the Mantel-Haenszel
method in STATA9.0.
SNP microarray analyses
Patient and colorectal cancer cell line DNAs were prepared
and hybridised to arrays (Affymetrix 10 K HuSNP and
Illumina Hap300, Hap370 and Hap550) using the manu-
facturer's standard protocols. Genotyping calls were made
using the manufacturer's software, resulting in call rates of
over 98% and sample failure rates of < 2% using good
quality DNA. LOH and copy number changes were scored
using the manufacturer's software in each case, supple-
mented by visual inspection of allele frequency plots
along each chromosome.
For the custom Goldengate arrays, designed to assess LOH
on 5q in FFPE tumour samples, the Illumina custom
probe design software was used to test the suitability of all
SNPs from dbSNP126 that mapped between the chromo-
some 5 centromere and the APC locus (~112 Mb). After
elimination of SNPs with low design scores, a panel of
360 remained. An additional 11 SNPs distal to the APC
gene were chosen to provide evidence that LOH extended
as far as the telomere; 7 were located on chromosome 5p
in order to give evidence of whole-chromosome LOH;
and 10 SNPs mapped elsewhere in the genome to give evi-
dence of copy number changes. 200–300 ng of each DNA
was hybridised to the arrays using the manufacturer's
standard protocols. After excluding SNPs with Gentrain
scores of less than 0.3, the Illumina Beadstudio software
was used to indicate LOH and copy number change on
5q, either in unpaired sample mode (for CRC cell lines)
or, after training on FFPE samples, in paired mode for the
colorectal adenomas. We found, however, that visual
inspection of allelic binning and manual corrections of
clear errors by two or more independent observers (SR,
KH, IT) improved data quality and allowed breakpoints to
be mapped more closely.
Microsatellite and analysis
Chromosome 5q microsatellite markers (D5S623,
D5S664, D5S407, D5S398, D5S2107, D5S624, D5S1990,
D5S2089, D5S647, D5S2019, D5S2003, D5S2041,
D5S2029, D5S107, D5S644, D5S669, D5S346) and in-
del polymorphisms (rs2067135, rs1305058, rs3087334,
rs2307799, rs1610940) were chosen according to their
location from the human genome March 2006 build
http://genome.ucsc.edu. PCR genotyping used a single
dye-labelled primer, the ABI 3730 sequencer and the
Genescan/Genotyper software. For analysis of CRC cell
lines, absence of one allele was required to score possible
LOH. The fact that paired constitutional DNA was not
available in most cases meant that this approach was
more useful for indicating definite retention of homozy-
gosity than mapping LOH.
Pyrosequencing
According to the manufacturer's standard protocols, a
Pyrosequencing assay was designed to discriminate
between the SMN1 and SMN2 genes using a C>T substitu-
tion [10] corresponding to SNP rs4916 (location
chr5:69,408,109 in the March 2006 Human Genome
Build). Briefly, primers were designed using the proprie-
tary Pyrosequencing assay design software, giving: (i)
biotinylated forward PCR primer, TCCTTTATTTTCCTTA-
CAGGGTTT; (ii) reverse PCR primer, ATGCTGGCAGACT-
TACTCCTTAAT; and sequencing primer,
TCCTTCTTTTTGATTTTGT. Allelic intensities were derived
from the standard Pyrosequencing software and used to
derive genotypes (see below).
Results
Mitotic recombination breakpoint mapping in colorectal 
cancer cell lines
We initially screened 49 colorectal cancer cell lines for
copy-neutral LOH at APC  using the Affymetrix 10 K
HuSNP array, alongside array-CGH analysis using a 1 Mb
density BAC-based array. Of the 14 cases that had under-
gone copy-neutral LOH involving APC, 10 showed break-
induced replication/mitotic recombination events,
extending from a location between the centromere and
the APC locus on chromosome 5q to the long-arm tel-
omere. In 4 of these 10 lines (C10, VACO4S, CACO2 and
C70), the LOH breakpoint was probably within or close
to a small region, 67.5–72.0 Mb, the site of a complex low
copy number repeat (LCR). Further genotyping using
highly polymorphic microsatellite markers and in/del
polymorphisms confirmed the locations of these break-
points and showed that they were likely to lie within or
just distal to the LCR (see Additional File 1). However,
poor coverage of polymorphic markers within the LCR
prevented finer scale mapping.BMC Medical Genetics 2009, 10:54 http://www.biomedcentral.com/1471-2350/10/54
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Mitotic breakpoint mapping using a custom SNP array in 
colorectal tumours
The preliminary observation from the colorectal cancer
cell lines that there might be a non-random distribution
of mitotic recombination breakpoints between the chro-
mosome 5 centromere (~50 Mb) and APC prompted us to
examine this phenomenon in a larger set of tumours. In
order to enrich for tumours with LOH [2] and to reduce
the frequency of confounding background events – such
as copy number changes related to chromosomal instabil-
ity in late lesions – we analysed early colorectal adenomas
from FAP patients who harboured germline mutations
close to codon 1300 of APC. Since these lesions were gen-
erally available as FFPE specimens, we set up a custom
SNP array (see Additional File 2) using the Illumina Gold-
engate platform that has previously proved suitable for
LOH analysis [11].
After verification using the colorectal cancer cell lines and
having excluded a small number of samples with 5q copy
number changes, 75/268 adenomas were both success-
fully analysed and showed LOH involving APC (Figure
1a). Apart from one loss of the whole chromosome, all
LOH events began at a breakpoint between the centro-
mere and APC  and extended as far as juxta-telomeric
SNPs, consistent with a mechanism of mitotic recombina-
tion through break-induced replication (Figure 1b). No
copy-neutral LOH involving an interstitial region of the
chromosome arm was detected. Moving along the chro-
mosome arm from the centromere, we mapped each
breakpoint to a region between the last constitutionally
heterozygous SNP showing no LOH to the first hetero-
zygous SNP with unequivocal LOH. In some cases, locali-
sation to a few kb was possible, but in other cases, such as
regions where SNP density was low owing to repeated
sequences, where SNPs were poorly informative, or where
some SNPs had ambiguous or discordant allelic calls,
breakpoints could only be mapped to a few megabases.
Breakpoint positions were therefore placed into 'bins' of 5
Mb regions.
Examination of the locations of the mitotic recombina-
tion breakpoints (Figure 2a) showed them to be non-ran-
dom compared with the expected flat distribution (χ2 =
33.8, 11 df, p < 0.001). There was a maximum frequency
of breakpoints between 65 Mb and 75 Mb, with an ele-
vated frequency extending as far as 80 Mb. There was actu-
ally a deficiency of breakpoints close to the APC locus.
These findings were consistent with our colorectal cancer
cell line data. Owing to poor SNP density within the 68–
71 Mb LCR itself – because of the presence of multiple
repeated sequences and the inability to distinguish true
SNPs from variants occurring in paralogous sequences in
cis – we were unable to fine-map our mitotic recombina-
tion breakpoints to determine whether they lay within the
LCR or just outside it.
Comparison between the mitotic and meiotic 
recombination maps
We compared the locations of the mitotic recombination
breakpoints with the meiotic recombination rate reported
by deCODE http://genome.ucsc.edu/cgi-bin/
hgTrackUi?hgsid=93924978&c=chr15&g=recombRate.
We calculated the mean meiotic recombination rate
within 5 Mb blocks between 50 Mb and 110 Mb on chro-
mosome 5 (Figure 2b) and compared it with the frequen-
cies of mitotic recombination breakpoints that we had
found. Although the meiotic recombination map was
more uniform than the mitotic map along the chromo-
some arm, linear regression analysis (Figure 2c) showed
that there was a strong association between the locations
of the breakpoints of the two forms of recombination (r =
0.729368, t = 3.449, d.f. = 10, p = 0.0062, 2-tailed).
Comparison between mitotic recombination and gain/
deletion of chromosome 5q in colorectal tumours
Although mitotic recombination is the foremost mecha-
nism of loss of heterozygosity in colorectal tumours, some
colorectal carcinomas acquire deletions or gains of 5q
around APC as an additional, later event during tumori-
genesis [12]. Were the mitotic recombination map to be
influenced primarily by chromosome breakage, we would
expect the copy number and mitotic recombination
breakpoint maps to be similar. Using array-CGH data
from the panel of 54 CRC cell lines and from 99 fresh-fro-
zen cancers (most samples taken from [12]), we deter-
mined the positions of breakpoints associated with
regions of copy number change between the chromosome
5 centromere and APC (Figure 2d). There was no correla-
tion between the locations of mitotic recombination and
copy number breakpoints (r = 0.73, t = 3.459, d.f. = 10, p
= 0.0062, 2-tailed), primarily because many copy number
breakpoints were close to the 5 centromere (~50–56 Mb).
Apart from the peri-centromeric region, the site with the
highest frequency of copy number breakpoints was 70–75
Mb, as it was for the mitotic and meiotic recombinbation
maps, but only a small proportion of all copy number
breakpoints was at this site.
Local sequence context and mitotic recombination 
breakpoints
We tested whether local G+C content in 5 Mb regions
between the chromosome 5 centromere and APC  was
associated with the frequency of mitotic recombination
breakpoints. A mean of 38.0% G+C content was found,
with a maximum of 40.7% at 75–80 Mb and a minimum
of 35.5% at 100–105 Mb. There was a strong correlation
between the location of mitotic recombination break-BMC Medical Genetics 2009, 10:54 http://www.biomedcentral.com/1471-2350/10/54
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Figure 1 (see legend on next page)BMC Medical Genetics 2009, 10:54 http://www.biomedcentral.com/1471-2350/10/54
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(a) Examples and (b) probable mechanism of LOH by mitotic recombination involving APC Figure 1 (see previous page)
(a) Examples and (b) probable mechanism of LOH by mitotic recombination involving APC. (a) Illumina Beadstu-
dio B allele frequency (upper) and Log R ratio plots from colorectal adenomas 3469-1-J-2 (breakpoint, 68–70 Mb) and 2079-L-
AC-1 (66–69 Mb). CRC cell lines C170 (~79 Mb) and VACO4S (70–75 Mb) are shown for comparison. LOH is indicated by 
the splitting of the heterozygous calls around the B = 0.5 region. Note the copy number loss in 3469-1-J-2 at the mitotic 
recombination boundary, suggesting germline copy number variation or deletion of sequences as a result of recombination. (b) 
A highly simplified version of LOH by mitotic recombination. It is envisaged that a protein-truncating mutation in APC is present 
on one copy of chromosome 5. The other chromosome 5 then suffers a double strand break on its long arm proximal to APC. 
Rather than using a sister chromatid for repair (for example, if the break has not occurred during or after S phase), repair is 
effected (dashed line) using the other copy of chromosome 5 as a template. This causes the distal long arms of the two chro-
mosome 5 s, including the APC mutation, to become genetically identical and hence LOH at APC occurs.
Locations of mitotic recombination breakpoints and comparison with meiotic recombination and deletion breakpoints Figure 2
Locations of mitotic recombination breakpoints and comparison with meiotic recombination and deletion 
breakpoints. (a) Frequencies and positions (in 5 Mb bins along chromosome 5) of mitotic recombination breakpoints in 
colorectal adenomas are shown. There is evident deviation from the flat distribution expected if cross-overs were random. (b) 
A plot of meiotic recombination breakpoints, expressed as cM/Mb, is shown, derived from the deCODE genetic map. (c) Lin-
ear regression of mitotic recombination frequency (y-axis) against meiotic recombination frequency (x-axis) is shown. (d) Fre-
quencies and positions (in 5 Mb bins along chromosome 5) of deletion/duplication breakpoints in colorectal carcinomas are 
shown; copy number changes on 5q are very rare in adenomas. There is evident deviation from the flat distribution expected, 
largely as a result of clustering at the centromere.BMC Medical Genetics 2009, 10:54 http://www.biomedcentral.com/1471-2350/10/54
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points and G+C content (r = 2.85, t = 3.67, d.f. = 10, p =
0.004, 2-tailed).
A genotyping assay to distinguish between the two major 
haplotypes within the polymorphic chr5:68–71 Mb LCR 
region
The 68–71 Mb LCR appeared to be one site with a high
frequency of mitotic recombination breakpoints in color-
ectal tumours. However, SNP density is very poor in this
region, owing to the exceptionally large number of highly
similar paralogous sequences. We therefore developed a
new genotyping assay to distinguish between the two
major haplotypes that have been described at this site,
hap1 of length 2.2 Mb and hap2 of length 1.6 Mb. The
SMN1 gene is present on both haplotypes as a single copy
and SMN2 is present as a single copy on haplotype 1 only.
Thus, hap1 is SMN1–SMN2  and hap2, SMN1  only.
(Although there have been reports of SMN1 and SMN2
alleles that have copy numbers different from those found
on haplotypes hap1 and hap2 [13], these occur at a very
low frequency (< 1%) and their relationships to haplo-
types hap1 and hap2 are uncertain; we therefore did not
consider the rare SMN1 and SMN2 copy number alleles
further.) We developed a high-throughput genotyping
assay based on the C>T difference (rs4916,
chr5:69,408,109) in exon 7 that differentiates the SMN1
gene from the SMN2 gene. In theory, allelotype hap1/
hap1 corresponds to an equal dosage of C and T alleles,
allelotype hap1/hap2 to a 2:1 C:T ratio and allelotype
hap2/hap2 to the presence of the C allele only. Using
Pyrosequencing, we initially genotyped a test series of 188
individuals for the two haplotypes. As controls, we used
colorectal cancer cell lines, that had known 5q copy
number and were homozygous for the 70 Mb repeat
region owing to somatic loss of heterozygosity. Although
the C:T allele ratios deviated slightly from those expected
(with the C allele dosage typically being over-estimated by
about 5%), the C:T ratios allowed us to distinguish three
genotype groups corresponding to hap1/hap1, hap1/
hap2 and hap2/hap2 (Figure 3).
We initially determined LD between SNPs present on
chromosome 5q on the Illumina Hap550 arrays and
rs4916 (Figure 4). We found that there was no significant
LD between rs4916 and any other SNP in the region from
the Hap550 panel. Even the two SNPs on the Hap550
arrays that flanked rs4916 – rs11955686 at chr5:
68,776,409 and rs13168712 at chr5:70,715,406 – were
isolated from rs4916 and other SNPs around. Although
the absence of LD around the LCR may reflect hyper-
recombination within the region or simply normal rates
of crossover, it was possible to conclude that the LCR does
not grossly suppress meiotic recombination.
Testing regions with high frequencies of mitotic 
recombination breakpoints for associations with 
colorectal cancer risk
If mitotic (or meiotic) recombination breakpoints tend to
cluster in certain regions, one possible explanation is that
the locations of recombination crossovers are selected in
normal cells to occur at sites that have no effects on gene
function. However, an alternative explanation for recom-
bination breakpoint clustering in mitotic recombination
is that the chromosome tends to have an intrinsic fragility
at that site. If this latter model were correct, inherited var-
iants near the most common breakpoints might modulate
LOH frequencies and hence be associated with differential
CRC susceptibility. There is evidence that such variation
can modulate meiotic recombination [14,15].
We tested whether inherited variation within close to
mitotic recombination breakpoints was associated with
colorectal cancer risk. Specifically, we determined SNP
genotype frequencies from the 65–80 Mb region of chro-
mosome 5 in our primary series of about 1,000 colorectal
tumour cases and 1,000 controls. We included all SNPs on
the Hap550 arrays (see Additional File 3), plus the follow-
ing 4 additional SNPs: rs4916; rs2561182, flanking the
LCR on the centromeric side; rs28409706, in a small
region of sequence with no paralogues within the LCR;
and rs7447545, flanking the LCR on the telomeric side.
We excluded all SNPs that failed Hardy-Weinberg equilib-
rium testing at P < 0.01. We then compared genotype fre-
quencies in cases and controls at the remaining 3,843
SNPs using the allelic, recessive and Cochran-Armitage
tests. The strongest evidence of association (Pallele test = 3.2
× 10-4, Figure 5) was found at rs2056169
(chr5:71,095,468). This association was suggestive, but
did not meet requirements for significance at P = 0.05
after correction for multiple testing. Subsequent analysis
in the VICTOR/QUASAR2/1958 series failed to confirm
any association (Pallele test = 0.86). None of the 4 additional
SNPs showed any association with colorectal cancer risk
under any of the tests of association, with Pallele test > 0.18
in all cases.
Discussion
Although maps of meiotic recombination are manifold,
very few maps of mitotic recombination exist. We rea-
soned that mitotic maps might provide not only basic
information about a process that is very important in dis-
ease, but also data that have more direct clinical benefits.
Tumours provide the most convenient means of mapping
mitotic recombination events, because the clonal expan-
sion that has occurred means that isolating rare recom-
binants is not required. It is important, however, to bear
in mind the caveats that any findings are derived from a
specific cell type and that data can only be gathered from
a restricted genomic region, usually between a chromo-BMC Medical Genetics 2009, 10:54 http://www.biomedcentral.com/1471-2350/10/54
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some centromere and a tumour suppressor gene. The APC
tumour suppressor provides a particularly good model for
study, because multiple tumours are available from FAP
patients, LOH generally occurs only in a restricted set of
cases, and LOH usually takes the form of mitotic recombi-
nation. Although some FAP polyps are polyclonal, we
focussed on larger tumours to minimise this problem and
found no evidence of 'two-level' LOH to suggest that pol-
yclonality affected our results.
We found that mitotic recombination breakpoints
between the centromere (~50 Mb) and the APC  locus
(~112 Mb) were non-random. There was no tendency for
breakpoints to occur closer to APC, as might be expected
were there constraints caused by uncovering recessive
lethal alleles or if mitotic recombination were favoured by
a longer length of residual chromosome arm that allowed
pairing with its homologue for recombination. An
increased frequency of breaks close and just distal to the
68–71 Mb LCR region was, however, notable, although
the region that showed a greater than expected breakpoint
frequency extended as far as about 85 Mb. Does the LCR
predispose to chromosome breakage, perhaps as a result
of replication fork stalling, and hence to mitotic recombi-
nation? Certainly, this is a plausible mechanism, although
the maximum breakpoint frequency is actually distal to
the LCR and long-range effects must be postulated to
explain this finding.
Typing hap1 and hap2 allelotypes using the Pyrosequencing assay Figure 3
Typing hap1 and hap2 allelotypes using the Pyrosequencing assay. The plots show the bins used to call hap1/hap1, 
hap1/hap2 and hap2/hap2 allelotypes based on C:T ratio frequencies in our whole case and control group. The trimodal distri-
bution corresponding to the three genotypes was evident with ratio bins of 0.05, but finer demarcation between the ratios, 
especially the hap1/hap2 versus hap1/hap1 groups, was possible using bins of 0.01 which showed a minimum frequency of calls 
at a T allele proportion of 0.38–0.39. The T allele proportion bins used to score allelotypes were therefore: hap2/hap2, 0.0–
0.1; hap1/hap2, 0.15–0.37; hap1/hap1, 0.39–1.0. The remaining samples (< 1%) were excluded. There was no significant depar-
ture of genotype frequencies from Hardy-Weinberg equilibrium (χ2
1 = 3.55, P = 0.07).BMC Medical Genetics 2009, 10:54 http://www.biomedcentral.com/1471-2350/10/54
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Although very fine mapping of mitotic recombination
breakpoints was not possible, it was intriguing to note
that the mitotic and meiotic maps were strongly corre-
lated. This finding is consistent with the model in which
break induced replication and meiotic recombination are
primarily influenced by similar processes, whether muta-
tional or selective in origin. In the past, other groups have
failed to find an association between the locations of mei-
otic and mitotic breakpoints in other genomic regions [7],
but recent advances in genomics may have provided bet-
ter baseline data on which to build our study.
In contrast to the mitotic and meiotic recombination
breakpoints, breakpoints involved in copy number
changes in colorectal tumours strongly clustered near the
chromosome 5 centromere. We suggest that this is the
region of greatest chromosomal fragility and that, since
most copy number changes occur in aneuploid/polyl-
ploid colorectal tumours [12], there is little selective dis-
advantage in aneusomy for the 5q arm. It is important to
bear in mind that chromosome 5q copy number changes
generally occur as additional genetic events in malignant
tumours, whereas LOH by mitotic recombination is an
early event that initiates tumorigenesis. We speculate that
breakage through the centromere cannot readily be
repaired by mitotic recombination, because the exposure
of peri-centromeric repeats produces a chromosome that
is prone to non-specific pairing and recombination. Since
the selective constraints on APC require two mutant cop-
ies in the early tumour cell, chromosome breaks must
occur between the centromere and APC, and hence be
repaired by break-induced replication.
LD between the two major CNV alleles in the 70 Mb
repeat region and flanking SNPs was extremely low, show-
ing that tagSNPs cannot always be used reliably as proxies
Haplotype block structure and LD relationships around the 68–71 Mb repeat region Figure 4
Haplotype block structure and LD relationships around the 68–71 Mb repeat region. "CNV" represents the hap1/
hap2 polymorphism; other SNPs are from the Illumina Hap550 arrays. The pairwise r2 values are shown, with standard Haplov-
iew http://www.broad.mit.edu/mpg/haploview/ shading to represent strength of correlation (darker = stronger).BMC Medical Genetics 2009, 10:54 http://www.biomedcentral.com/1471-2350/10/54
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for copy number variants [16,17]. Neither the CNV geno-
type nor any other SNP in the region of maximal mitotic
recombination was associated with an increased risk of
colorectal cancer. This may be a true reflection of a lack of
genetic variation that influences LOH breakpoints, but it
must be borne in mind that LOH at APC only affects a
minority of colorectal tumours and that LOH acts on ade-
noma formation rather than progression, the conse-
quences being that any effect of differential LOH
frequencies on cancer risk may be weak overall.
Conclusion
In summary, mitotic recombination is an important
mutational process that occurs through cross-over repair
initiated at non-random 'breakpoints'. The influences on
meiotic and mitotic recombination rates seem similar,
although they have not yet been elucidated. There is a pos-
sible role for LCRs in promoting mitotic recombination,
but other selective or mutational factors must also be
influential, in some cases perhaps suppressing cross-
overs, resulting in few breakpoints close to APC. The
absence of an association between polymorphisms in
regions of frequent mitotic recombination on 5q and
colorectal cancer risk suggests that local influences over
the rate of loss of heterozygosity at APC are not factors
that explain inter-individual differences in susceptibility
to colorectal cancer.
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